FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications - FDA Press Releases

FDA update on the ongoing investigation into angiotensin II receptor blocker impurities, recalls and current findings.

from FDA Press Releases RSS Feed http://bit.ly/2VsqKhy
via IFTTT